STUDY OF EFFECT, ACTION MECHANISM, AND SAFETY OF EXTRACT ETHANOL OF MANGOSTEEN (GARCINIA MANGOSTANA L.) RIND AS ANTIDIABETIC MELLITUS
Mangosteen (Garcinia mangostana L.) rind is one of the traditional medicine that have antihyperglycemic effect. This material is easy to find in Indonesia and has been generally used by the community as traditional medicine. The compounds ?mangostin, ?-mangostin, and xanthones contained in the man...
Saved in:
Main Author: | |
---|---|
Format: | Dissertations |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/68648 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
id |
id-itb.:68648 |
---|---|
institution |
Institut Teknologi Bandung |
building |
Institut Teknologi Bandung Library |
continent |
Asia |
country |
Indonesia Indonesia |
content_provider |
Institut Teknologi Bandung |
collection |
Digital ITB |
language |
Indonesia |
description |
Mangosteen (Garcinia mangostana L.) rind is one of the traditional medicine that
have antihyperglycemic effect. This material is easy to find in Indonesia and has
been generally used by the community as traditional medicine. The compounds ?mangostin, ?-mangostin, and xanthones contained in the mangosteen rind were
used as markers. This study aims to examine the effect, mechanism of action, safety
profile, and establish quality standardization of the ethanol extract of mangosteen
rind (EEKM).
EEKM used in this research was obtained from PT. Borobudur and is an extract
from maceration using 70% ethanol as a solvent with the addition of Maltodextrin
as a filler. The research stages include testing the effect, mechanism of action, and
safety of EEKM in silico and in vivo, as well as quality standardization of extracts
and analysis of marker compound content (?-mangostin, ?-mangostin, and
xanthone).
Molecular docking study showed that ?-mangostin, ?-mangostin, and xanthone
ligand could bind to the receptors/enzymes GLUT-4, PPAR-?, DPP-4, Aldose
reductase, GLP-1, GSK-3?, GSK-3?, CD-4, and SGLT-2 indicated by the values of
binding affinity which were comparable to those of the comparator ligands, drugs
having the same target. Meanwhile, through molecular dynamic analysis of the
SGLT-2 receptor, ?-mangostin showed higher stability compared to ?-mangostin
and xanthone indicating its highest role in binding to the SGLT-2 receptor.
In vivo test in rats induced with high-fat diet (HFD) and 35 mg/kg Streptozotocin
showed that the administration of each dose of EEKM (100 mg/kg bw rat, 200
mg/kg bw rat, and 400 mg/kg bw rat) had glucose lowering effect with EEKM at
400 mg/kg bw rat as the most potent. Observation on the expression of the SGLT-2
gene in the kidneys through the RT-qPCR method showed significant differences
(p<0.05) between the EEKM 200 and 400 mg/kg bw groups compared to the control
group, and there was no significant difference against the Empagliflozin group. The
animal blood serum was analyzed using the ELISA method and showed significant
differences (p<0.05) in the increase in GLUT-4 between the control group
(Na.CMC 0.3%) compared to the 200 and 400 mg/kg EEKM groups. Meanwhile
the results of the analysis on the increase in PPAR-? and decrease in SGLT-2
showed significant differences(p<0.05) between the control group (Na.CMC 0.3%)
compared to all EEKM groups (100, 200, 400 mg/kg bw). Similar results were also
shown by the comparator drugs (Empagliflozin, Pioglitazone, and Metformin).
Nevertheless, it can be concluded that EEKM at a certain dose can have an effect
as antidiabetic mellitus through the mechanism of action of increasing the
expression of GLUT-4 and PPAR-?, as well as decreasing the expression of SGLT2.
The safety test using a virtual toxicity test, Protox-II Web Server predicted that ?mangostin with an LD50 of class 5, did not show any toxic effects on all test
parameters (hepatotoxic, carcinogenic, immunotoxic, mutagenic, and cytotoxic).
Therefore, is estimated that this compound is the safest compound in EEKM,
compared to ?-mangostin and xanthone, which were only in class 4 toxicity and
showed toxic effects on several organs. Furthermore, the chronic toxicity test for 6
months on the mangosteen (Garcinia mangostana L.) rind extract did not show any
difference in the behavior and mortality of the test animals. In addition, EEKM at
all test doses showed no significant difference compared to the control group
(Na.CMC 0.3%), as well as between groups in terms of parameters of body weight,
hematology, and organ weight. However, through biochemical observations, there
was a significant difference (p<0.05) between the control group (Na.CMC 0.3%)
compared to the EEKM group at doses of 200 and 400 mg/kg bw in the GOT
parameters of male and female rats and triglycerides and creatinine upon
administration of EEKM at 400 mg/kg body weight in male rats. This was also seen
in histological observations, which showed liver abnormalities when EEKM was
given at a dose of 200 mg/kg bw in female rats and 400 mg/kg bw in male and
female rats. Organ abnormalities were also occurred in the histological
observations of the male rat kidney given EEKM 400 mg/kg bw. Taken together,
results of this study suggest that EEKM at a dose of 100 mg/kg bw is the the most
suitable dose for long-term use (6 months).
Based on the results of the extract quality analysis test, the EEKM used in the study
was found to meet the standardization of specific and non-specific parameters. The
extract contained alkaloids, flavonoids, saponins, tannins, and triterpenoids. The
contents of markers ?-mangostin, ?-mangostin, and xanthone, determined by
HPLC, were 19.88%, 16.15%, and 7.66%, respectively. Their Rf values and
spectral of each compounds were almost similar to the components of EEKM, based
on TLC-densitometry.
|
format |
Dissertations |
author |
Mahmudah, Rifa'atul |
spellingShingle |
Mahmudah, Rifa'atul STUDY OF EFFECT, ACTION MECHANISM, AND SAFETY OF EXTRACT ETHANOL OF MANGOSTEEN (GARCINIA MANGOSTANA L.) RIND AS ANTIDIABETIC MELLITUS |
author_facet |
Mahmudah, Rifa'atul |
author_sort |
Mahmudah, Rifa'atul |
title |
STUDY OF EFFECT, ACTION MECHANISM, AND SAFETY OF EXTRACT ETHANOL OF MANGOSTEEN (GARCINIA MANGOSTANA L.) RIND AS ANTIDIABETIC MELLITUS |
title_short |
STUDY OF EFFECT, ACTION MECHANISM, AND SAFETY OF EXTRACT ETHANOL OF MANGOSTEEN (GARCINIA MANGOSTANA L.) RIND AS ANTIDIABETIC MELLITUS |
title_full |
STUDY OF EFFECT, ACTION MECHANISM, AND SAFETY OF EXTRACT ETHANOL OF MANGOSTEEN (GARCINIA MANGOSTANA L.) RIND AS ANTIDIABETIC MELLITUS |
title_fullStr |
STUDY OF EFFECT, ACTION MECHANISM, AND SAFETY OF EXTRACT ETHANOL OF MANGOSTEEN (GARCINIA MANGOSTANA L.) RIND AS ANTIDIABETIC MELLITUS |
title_full_unstemmed |
STUDY OF EFFECT, ACTION MECHANISM, AND SAFETY OF EXTRACT ETHANOL OF MANGOSTEEN (GARCINIA MANGOSTANA L.) RIND AS ANTIDIABETIC MELLITUS |
title_sort |
study of effect, action mechanism, and safety of extract ethanol of mangosteen (garcinia mangostana l.) rind as antidiabetic mellitus |
url |
https://digilib.itb.ac.id/gdl/view/68648 |
_version_ |
1822278273062666240 |
spelling |
id-itb.:686482022-09-19T07:56:09ZSTUDY OF EFFECT, ACTION MECHANISM, AND SAFETY OF EXTRACT ETHANOL OF MANGOSTEEN (GARCINIA MANGOSTANA L.) RIND AS ANTIDIABETIC MELLITUS Mahmudah, Rifa'atul Indonesia Dissertations Diabetes mellitus, Garcinia mangostana L., ?-mangostin, ?-mangostin, xanthones, Ethanol Extract of Mangosteen Rind (EEKM). INSTITUT TEKNOLOGI BANDUNG https://digilib.itb.ac.id/gdl/view/68648 Mangosteen (Garcinia mangostana L.) rind is one of the traditional medicine that have antihyperglycemic effect. This material is easy to find in Indonesia and has been generally used by the community as traditional medicine. The compounds ?mangostin, ?-mangostin, and xanthones contained in the mangosteen rind were used as markers. This study aims to examine the effect, mechanism of action, safety profile, and establish quality standardization of the ethanol extract of mangosteen rind (EEKM). EEKM used in this research was obtained from PT. Borobudur and is an extract from maceration using 70% ethanol as a solvent with the addition of Maltodextrin as a filler. The research stages include testing the effect, mechanism of action, and safety of EEKM in silico and in vivo, as well as quality standardization of extracts and analysis of marker compound content (?-mangostin, ?-mangostin, and xanthone). Molecular docking study showed that ?-mangostin, ?-mangostin, and xanthone ligand could bind to the receptors/enzymes GLUT-4, PPAR-?, DPP-4, Aldose reductase, GLP-1, GSK-3?, GSK-3?, CD-4, and SGLT-2 indicated by the values of binding affinity which were comparable to those of the comparator ligands, drugs having the same target. Meanwhile, through molecular dynamic analysis of the SGLT-2 receptor, ?-mangostin showed higher stability compared to ?-mangostin and xanthone indicating its highest role in binding to the SGLT-2 receptor. In vivo test in rats induced with high-fat diet (HFD) and 35 mg/kg Streptozotocin showed that the administration of each dose of EEKM (100 mg/kg bw rat, 200 mg/kg bw rat, and 400 mg/kg bw rat) had glucose lowering effect with EEKM at 400 mg/kg bw rat as the most potent. Observation on the expression of the SGLT-2 gene in the kidneys through the RT-qPCR method showed significant differences (p<0.05) between the EEKM 200 and 400 mg/kg bw groups compared to the control group, and there was no significant difference against the Empagliflozin group. The animal blood serum was analyzed using the ELISA method and showed significant differences (p<0.05) in the increase in GLUT-4 between the control group (Na.CMC 0.3%) compared to the 200 and 400 mg/kg EEKM groups. Meanwhile the results of the analysis on the increase in PPAR-? and decrease in SGLT-2 showed significant differences(p<0.05) between the control group (Na.CMC 0.3%) compared to all EEKM groups (100, 200, 400 mg/kg bw). Similar results were also shown by the comparator drugs (Empagliflozin, Pioglitazone, and Metformin). Nevertheless, it can be concluded that EEKM at a certain dose can have an effect as antidiabetic mellitus through the mechanism of action of increasing the expression of GLUT-4 and PPAR-?, as well as decreasing the expression of SGLT2. The safety test using a virtual toxicity test, Protox-II Web Server predicted that ?mangostin with an LD50 of class 5, did not show any toxic effects on all test parameters (hepatotoxic, carcinogenic, immunotoxic, mutagenic, and cytotoxic). Therefore, is estimated that this compound is the safest compound in EEKM, compared to ?-mangostin and xanthone, which were only in class 4 toxicity and showed toxic effects on several organs. Furthermore, the chronic toxicity test for 6 months on the mangosteen (Garcinia mangostana L.) rind extract did not show any difference in the behavior and mortality of the test animals. In addition, EEKM at all test doses showed no significant difference compared to the control group (Na.CMC 0.3%), as well as between groups in terms of parameters of body weight, hematology, and organ weight. However, through biochemical observations, there was a significant difference (p<0.05) between the control group (Na.CMC 0.3%) compared to the EEKM group at doses of 200 and 400 mg/kg bw in the GOT parameters of male and female rats and triglycerides and creatinine upon administration of EEKM at 400 mg/kg body weight in male rats. This was also seen in histological observations, which showed liver abnormalities when EEKM was given at a dose of 200 mg/kg bw in female rats and 400 mg/kg bw in male and female rats. Organ abnormalities were also occurred in the histological observations of the male rat kidney given EEKM 400 mg/kg bw. Taken together, results of this study suggest that EEKM at a dose of 100 mg/kg bw is the the most suitable dose for long-term use (6 months). Based on the results of the extract quality analysis test, the EEKM used in the study was found to meet the standardization of specific and non-specific parameters. The extract contained alkaloids, flavonoids, saponins, tannins, and triterpenoids. The contents of markers ?-mangostin, ?-mangostin, and xanthone, determined by HPLC, were 19.88%, 16.15%, and 7.66%, respectively. Their Rf values and spectral of each compounds were almost similar to the components of EEKM, based on TLC-densitometry. text |